Augustine Lawlor - Jun 30, 2025 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
Chief Operating Officer
Signature
/s/ Douglas E. Onsi, as attorney-in-fact for Augustine Lawlor
Stock symbol
LPTX
Transactions as of
Jun 30, 2025
Transactions value $
$0
Form type
4
Date filed
7/1/2025, 04:30 PM
Previous filing
Apr 1, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LAWLOR AUGUSTINE Chief Operating Officer C/O LEAP THERAPEUTICS, INC., 47 THORNDIKE STREET SUITE B1-1, CAMBRIDGE /s/ Douglas E. Onsi, as attorney-in-fact for Augustine Lawlor 2025-07-01 0001262327

Augustine Lawlor is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

The reporting person is no longer serving as the Chief Operating Officer of Leap Therapeutics, Inc., effective June 30, 2025. As a result, the reporting person is no longer subject to Section 16 in connection with his transactions in the equity securities of Leap Therapeutics, Inc. and therefore will no longer report any such transactions on Form 4 or Form 5.